Hyams DM - Search Results

1

Prolongation of survival of nude mice bearing human colon cancer. Treatment with yttrium 90-labeled anti-carcinoembryonic antigen antibody.

Hyams DM, Esteban JM, Beatty BG, Wanek PM, Beatty JD. Hyams DM, et al. Arch Surg. 1989 Feb;124(2):175-9. doi: 10.1001/archsurg.1989.01410020045007. Arch Surg. 1989. PMID: 2916938

2

Radioimmunotherapy of human colon carcinomatosis xenograft with 90Y-ZCE025 monoclonal antibody: toxicity and tumor phenotype studies.

Esteban JM, Hyams DM, Beatty BG, Merchant B, Beatty JD. Esteban JM, et al. Among authors: hyams dm. Cancer Res. 1990 Feb 1;50(3 Suppl):989s-992s. Cancer Res. 1990. PMID: 2297752

3

Impact of radiolabeled antibody imaging on management of colon cancer.

Beatty JD, Hyams DM, Morton BA, Beatty BG, Williams LE, Yamauchi D, Merchant B, Paxton RJ, Shively JE. Beatty JD, et al. Among authors: hyams dm. Am J Surg. 1989 Jan;157(1):13-9. doi: 10.1016/0002-9610(89)90413-3. Am J Surg. 1989. PMID: 2910118

4

Effect of yttrium-90-labeled anti-carcinoembryonic antigen monoclonal antibody on the morphology and phenotype of human tumors grown as peritoneal carcinomatosis in athymic mice.

Esteban JM, Hyams DM, Beatty BG, Wanek P, Beatty JD. Esteban JM, et al. Among authors: hyams dm. Cancer. 1989 Apr 1;63(7):1343-52. doi: 10.1002/1097-0142(19890401)63:7<1343::aid-cncr2820630720>3.0.co;2-j. Cancer. 1989. PMID: 2920362

5

Therapy of peritoneal carcinomatosis of human colon cancer xenografts with yttrium 90-labeled anti-carcinoembryonic antigen antibody ZCE025.

Hyams DM, Esteban JM, Lollo CP, Beatty BG, Beatty JD. Hyams DM, et al. Arch Surg. 1987 Nov;122(11):1333-7. doi: 10.1001/archsurg.1987.01400230121021. Arch Surg. 1987. PMID: 3675197

6

Evaluation of a short-stay program for patients undergoing mastectomy.

Wagman LD, Terz JJ, Hill LR, Beatty JD, Kokal WA, Riihimaki DU, Hyams DM, Grant M, Hart A, Kirshner T, et al. Wagman LD, et al. Among authors: hyams dm. J Surg Oncol. 1989 Jun;41(2):98-102. doi: 10.1002/jso.2930410209. J Surg Oncol. 1989. PMID: 2724987

7

Comparison of postoperative wound complications and early cancer recurrence between patients undergoing mastectomy with or without immediate breast reconstruction.

O'Brien W, Hasselgren PO, Hummel RP, Coith R, Hyams D, Kurtzman L, Neale HW. O'Brien W, et al. Am J Surg. 1993 Jul;166(1):1-5. doi: 10.1016/s0002-9610(05)80572-0. Am J Surg. 1993. PMID: 8392300

8

Clinical advances in treatment options and diagnostics: new tools in the management of breast cancer and colon cancer.

Hyams DM. Hyams DM. Manag Care. 2010 Oct;19(10 Suppl 4):3-11. Manag Care. 2010. PMID: 21128521 No abstract available.

9

Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays.

Hyams DM, Schuur E, Angel Aristizabal J, Bargallo Rocha JE, Cabello C, Elizalde R, García-Estévez L, Gomez HL, Katz A, Nuñez De Pierro A. Hyams DM, et al. J Surg Oncol. 2017 May;115(6):647-662. doi: 10.1002/jso.24561. Epub 2017 Feb 17. J Surg Oncol. 2017. PMID: 28211064 Free PMC article. Review.

10

Laparoscopic splenectomy by the lateral approach: a safe and effective alternative to open splenectomy for hematologic diseases.

Smith CD, Meyer TA, Goretsky MJ, Hyams D, Luchette FA, Fegelman EJ, Nussbaum MS. Smith CD, et al. Surgery. 1996 Nov;120(5):789-94. doi: 10.1016/s0039-6060(96)80085-7. Surgery. 1996. PMID: 8909512 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters